The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease

British Journal of Dermatology

Volumn 139, Issue 4, 1998, Pages 622-629

  Ohtsuka, T ^a   Tamura, T ^b   Yamakage, A ^a   Yamazaki, S ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAPILLARY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; MICROSCOPY; NAIL BED; PREDICTION; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAPILLARIES; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; MALE; MICROSCOPY; MIDDLE AGED; NAILS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 0031691811     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02458.x     Document Type: Article

References (29)

1. Belch JJF. Raynaud's phenomenon. Curr Opin Rheum 1990; 2: 937-41.
2. Campbell PM, LeRoy EC. Raynaud's phenomenon. Semin Arthritis Rheum 1986; 16: 92-105.
3. Klippel JH. Raynaud's phenomenon: the French tricolor. Arch Intern Med 1991; 151: 2389-93.
4. Harper FE, Maricq HR, Turner RE et al. A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. Am J Med 1982; 72: 883-8.
5. Maricq HR, Harper FE, Khan MM et al. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983; 1: 195-205.
6. Priollet P, Vayssairat M, Housset E. How to classify Raynaud's phenomenon: long-term follow-up study of 73 cases. Am J Med 1987; 83: 494-8.
7. Fitzgerald O, O'Connor GT, Spencer-Green G. Prospective study of the evolution of Raynaud's phenomenon. Am J Med 1988; 84: 718-26.
8. Zufferey P, Depairon M, Chamot AM, Monti M. Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 1992; 11: 536-41.
9. Luggen M, Belhorn L, Evans T et al. The evolution of Raynaud's phenomenon: a long-term prospective study. J Rheumatol 1995; 22: 2226-32.
10. Blockmans D, Beyens G, Verhaeghe R. Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheumatol 1996; 15: 148-53.
11. LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum 1980; 23: 341-3.
12. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980: 23: 581-90.
13. Tan EN, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
14. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
15. Sharp GC, Irvin WS, Tan EM et al. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148-59.
16. Arnett FC, Edworthy SM, Bloch DA et al. The American Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
17. Ohtsuka T, Ishikawa H. Statistical definition of nailfold capillary pattern in patients with systemic sclerosis. Dermatology 1994; 188: 286-9.
18. Maricq HR, Weinlich MC, Keil JE, LeRoy EC. Prevalence of Raynaud phenomenon in the general population: a preliminary study by questionnaire. J Chronic Dis 1986; 39: 423-7.
19. Gerbracht DD, Steen VD, Ziegler GL et al. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum 1985; 28: 89-92.
20. Rouen LR, Terry EN, Doft BH et al. Classifications and measurement of surface microvessels in man. Microvasc Res 1972; 4: 285-92.
21. Statham BN, Rowell NR. Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome. Acta Derm Venereol (Stockh) 1986; 66: 139-43.
22. Lefford F, Edwards JCW. Nailfold capillary microscopy in connective tissue diseases: a quantitative morphological analysis. Ann Rheum Dis 1986; 45: 741-9.
23. Studer A, Hunziker T, Lutolf O et al. Quantitative nailfold capillary microscopy in cutaneous and systemic lupus erythematosus and localized and systemic scleroderma. J Am Acad Dermatol 1991; 24: 941-5.
24. Michoud B, Carpentier PH. Digitized nailfold capillaroscopy. Vasa 1994; 23: 35-42.
25. Kabasakal Y, Elvins DM, Ring EF, McHugh NJ. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996; 55: 507-12.
26. Scheja A, Akesson A, Niewierowicz I et al. Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis 1996; 55: 52-6.
27. Weinrich MC, Maricq HR, Keil JE et al. Prevalence of Raynaud's phenomenon in the adult population of South Carolina. J Clin Epidemiol 1986; 43: 1343-9.
28. Maricq HR, Spencer-Green G, LeRoy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 1976; 61: 862-70.
29. Lee P, Leung FYK, Alderdice C, Armstrong S. Nailfold capillary microscopy in the connective tissue disease: a semiquantitative assessment. J Rheumatol 1983; 10: 930-8.